Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1500 of 1631 entries
View as:

Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02258451 Org: User:
Start: 06/04/15 End: 10/28/22 Due: 10/28/23

Dose-finding Study for the Ultralow-dose Levonorgestrel Intrauterine Contraceptive System (LCS)

Phase: N/A Priority: Normal
NCT ID: NCT00185380 Org: User:
Start: 04/30/05 End: 12/31/08 Due: 12/31/09

A Study Called NATION-OS to Learn About the Link Between N-terminal proBNP (NT-proBNP) Levels and Medical Problems Due to Heart Failure (HF) in German Patients With HF

Phase: N/A Priority: Normal
NCT ID: NCT04915118 Org: User:
Start: 06/17/21 End: 11/30/21 Due: 11/30/22

Patient and Physician Knowledge of Key Safety Messages

Phase: N/A Priority: Normal
NCT ID: NCT01907048 Org: User:
Start: 09/15/14 End: 04/15/20 Due: 04/15/21

Extension Program for Bay 43-9006

Phase: N/A Priority: Normal
NCT ID: NCT00657254 Org: User:
Start: 12/31/02 End: 06/30/05 Due: 06/30/06

Sorafenib for Residue Disease After Resection With Curative Intent

Phase: N/A Priority: Normal
NCT ID: NCT01751763 Org: User:
Start: 07/09/13 End: 09/08/17 Due: 09/08/18

A Trial to Learn How Safe Vericiguat (BAY1021189) is and the Way the Body Absorbs, Distributes and Gets Rid of Vericiguat in Participants With Liver Disease and in Age-, Weight- and Gender-matched Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04722562 Org: User:
Start: 07/16/14 End: 04/30/15 Due: 04/30/16

Test the Phototoxicity of Sunscreen Products

Phase: N/A Priority: Normal
NCT ID: NCT02802930 Org: User:
Start: 04/20/15 End: 04/26/15 Due: 04/26/16

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01516840 Org: User:
Start: 03/31/12 End: 01/31/14 Due: 01/31/15

Study to Gather Information About the Actual Use of an Adhesive Patch Placed on the Skin to Deliver Oxytrol Through the Skin Into the Bloodstream.

Phase: N/A Priority: Normal
NCT ID: NCT04534491 Org: User:
Start: 05/25/10 End: 06/22/11 Due: 06/22/12

A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy, DR)

Phase: N/A Priority: Normal
NCT ID: NCT04795726 Org: User:
Start: 03/10/21 End: 06/30/21 Due: 06/30/22

Study in Healthy Young Women to Investigate the Pharmacodynamics, Pharmacokinetics and Safety of Vilaprisan

Phase: N/A Priority: Normal
NCT ID: NCT02262663 Org: User:
Start: 10/31/14 End: 12/31/15 Due: 12/31/16

Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon

Phase: N/A Priority: Normal
NCT ID: NCT02486640 Org: User:
Start: 09/08/15 End: 01/16/20 Due: 01/16/21

A 2-part Trial to Learn More About How BAY1817080 Works, How Safe it is, and What the Right Dose is for Participants With Diabetic Neuropathic Pain

Phase: N/A Priority: Normal
NCT ID: NCT04641273 Org: User:
Start: 01/22/21 End: 10/18/21 Due: 10/18/22

ODiXahip - a Phase IIa Dose Escalating Proof of Principle Trial

Phase: N/A Priority: Normal
NCT ID: NCT00839826 Org: User:
Start: 12/31/02 End: 11/30/03 Due: 11/30/04

18613 - Sun Protection Factor Assay

Phase: N/A Priority: Normal
NCT ID: NCT02757014 Org: User:
Start: 10/19/15 End: 10/22/15 Due: 10/22/16

Gadobutrol Magnevist-controlled Body Study

Phase: N/A Priority: Normal
NCT ID: NCT01050829 Org: User:
Start: 01/31/10 End: 04/30/11 Due: 04/30/12

A Study to Evaluate The Effects Of a Multivitamin/Mineral With Ginko In Subjects With Age Associated Memory Impairment

Phase: N/A Priority: Normal
NCT ID: NCT01160692 Org: User:
Start: 02/28/06 End: 07/31/08 Due: 07/31/09

Observational Study on Contraception With Essure in France

Phase: N/A Priority: Normal
NCT ID: NCT02510443 Org: User:
Start: 06/23/08 End: 11/25/16 Due: 11/25/17

Evaluation of Bay 59-8862 in Patients With Aggressive, Refractory Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00044551 Org: User:
Start: 02/28/02 End: 07/31/03 Due: 07/31/04

Duration of Treatment With Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01585974 Org: User:
Start: 10/31/12 End: 11/30/15 Due: 11/30/16

Impact of SH T00658ID as Compared to a Monophasic Contraceptive Containing Ethinylestradiol and Levonorgestrel (SH D01155E) on Hemostatic Parameters

Phase: N/A Priority: Normal
NCT ID: NCT00318799 Org: User:
Start: 04/30/06 End: 05/31/07 Due: 05/31/08

Rivaroxaban vs Warfarin for SPAF in Multi-morbid Patients

Phase: N/A Priority: Normal
NCT ID: NCT03374540 Org: User:
Start: 12/01/17 End: 08/30/19 Due: 08/30/20

The Aim of This Study is to Estimate the Discontinuation Rate of Low-dose Levonorgestrel-releasing Intrauterine System Due to Self-reported Unacceptable Menstrual Bleeding Pattern in Spanish Women Who Are Using it for the First Time How Intrauterine System for Long Acting Contraception

Phase: N/A Priority: Normal
NCT ID: NCT04785950 Org: User:
Start: 02/21/21 End: 05/04/23 Due: 05/04/24

Evaluate the Effectiveness of Intravitreal (IVT) Aflibercept Injection in Clinical Practice in naïve Patients With Neovascular Age-related Macular Degeneration (nAMD)

Phase: N/A Priority: Normal
NCT ID: NCT03411941 Org: User:
Start: 02/28/18 End: 03/01/19 Due: 03/01/20